AVEG 010

A Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination with a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Na?ve Individuals

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) July 16, 1992
HIVAC-1e,rgp120/HIV-1 SF-2,MN rgp120 Env gp160 B; Env gp120 B SF-2; Env gp120 B
HIVAC-1e Viral Vector - Pox
rgp120/HIV-1 SF-2 Protein
MN rgp120 Protein
USA 56